Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 72,184 | 43,446 | 69,313 | 43,836 | 18,151 |
| Marketable Securities | 350,905 | 120,591 | 106,770 | 150,586 | 181,443 |
| Receivables | 197 | 496 | 1,828 | 1,802 | 838 |
| TOTAL | $426,555 | $167,606 | $181,499 | $197,843 | $202,925 |
| Non-Current Assets | |||||
| PPE Net | 3,342 | 3,496 | 3,747 | 3,815 | 3,813 |
| Intangibles | 27,190 | 30,690 | 30,690 | 30,690 | 45,190 |
| Other Non-Current Assets | 3,114 | 2,759 | 3,129 | 3,490 | 3,842 |
| TOTAL | $33,646 | $36,945 | $37,566 | $37,995 | $52,845 |
| Total Assets | $460,201 | $204,551 | $219,065 | $235,838 | $255,770 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,721 | N/A | N/A | N/A | 2,362 |
| Accounts payable and accrued liabilities | 836 | 685 | 997 | 1,048 | 568 |
| Accrued Expenses | 10,253 | 7,851 | 7,023 | 8,459 | 8,007 |
| Other current liabilities | N/A | 4,621 | 7,585 | 3,372 | N/A |
| TOTAL | $14,176 | $14,488 | $16,977 | $14,206 | $12,200 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 9,313 | 7,781 | 7,922 | 12,275 | 13,595 |
| TOTAL | $9,313 | $7,781 | $7,922 | $12,275 | $13,595 |
| Total Liabilities | $23,489 | $22,269 | $24,899 | $26,481 | $25,795 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,664 | 46,482 | 39,615 | 39,615 | 39,567 |
| Common Shares | 47 | 40 | 40 | 40 | 40 |
| Retained earnings | -1,123,459 | -1,103,007 | -1,089,634 | -1,073,096 | -1,051,196 |
| Other shareholders' equity | 2,548 | 2,592 | 2,587 | 2,589 | 2,608 |
| TOTAL | $436,712 | $182,282 | $194,166 | $209,357 | $229,975 |
| Total Liabilities And Equity | $460,201 | $204,551 | $219,065 | $235,838 | $255,770 |